A report back on Pedro Cahn's session - Novel treatment strategies
Pedro Cahn presented on what treatments were used by low and middle income countries (LMIC) and what they could look forward to in the future. The WHO recommendation for these countries is the use of TDF + 3TC + DTG as first line, except for women of child-bearing age where EFV was the preferred third agent. EFV and PI based regimens are now second/third line treatments. As not INSTIs are available in these countries, he also went through the currently available INSTIs. The new NNRTI was also discussed as well as other pipeline treatments (injectables, implants, monoclonal antibodies)
